0001486189-23-000023.txt : 20230705 0001486189-23-000023.hdr.sgml : 20230705 20230705135521 ACCESSION NUMBER: 0001486189-23-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lau Stanley K. CENTRAL INDEX KEY: 0001950824 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41097 FILM NUMBER: 231067776 MAIL ADDRESS: STREET 1: C/O CARDIO DIAGNOSTICS HOLDINGS INC. STREET 2: 400 N. ABERDEEN ST., SUITE 900 CITY: CHICAGO STATE: IL ZIP: 60642 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardio Diagnostics Holdings, Inc. CENTRAL INDEX KEY: 0001870144 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870925574 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 N ABERDEEN ST, SUITE 900 CITY: CHICAGO STATE: IL ZIP: 60642 BUSINESS PHONE: 855-226-9991 MAIL ADDRESS: STREET 1: 400 N ABERDEEN ST, SUITE 900 CITY: CHICAGO STATE: IL ZIP: 60642 FORMER COMPANY: FORMER CONFORMED NAME: Mana Capital Acquisition Corp. DATE OF NAME CHANGE: 20210629 4 1 primary_doc.xml PRIMARY DOCUMENT X0407 4 2023-06-30 0 0001870144 Cardio Diagnostics Holdings, Inc. CDIO 0001950824 Lau Stanley K. C/O CARDIO DIAGNOSTICS HOLDINGS INC. 400 N. ABERDEEN ST., SUITE 900 CHICAGO IL 60642 1 0 0 0 0 Common Stock 2023-06-30 4 M 0 21008 1.19 A 21008 D Common Stock 2023-07-01 4 M 0 8403 1.19 A 29411 D Restricted Stock Units 0 2023-06-30 4 M 0 25000 0 A 2023-06-30 2023-12-31 Common Stock 25000 25000 D Restricted Stock Units 0 2023-07-01 4 M 0 14000 0 A 2023-07-01 2024-01-31 Common Stock 14000 39000 D Represents the settlement of restricted stock units (RSUs) that vested on June 30, 2023 through the issuance of shares of Common Stock. Represents the settlement of restricted stock units (RSUs) that vested on July 1, 2023 through the issuance of shares of Common Stock. Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On June 30, 2023, $25,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I. On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023. The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On July 1, 2023, $10,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I. On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on July 31, 2023, (ii) $2,000 in value on August 31, 2023, (iii) $2,000 in value on September 30, 2023; (iv) $2,000 in value on October 31, 2023; (v) $2,000 in value on November 30, 2023; (vi) $2,000 in value on December 31, 2023 and (vii) $2,000 in value on January 31, 2024. /s/ Elisa Luqman as attorney-in-fact for Stanley Lau 2023-07-05